Innovative Therapeutics ONWARD Medical continues to develop cutting-edge spinal cord stimulation therapies like ARC-EX and ARC-IM, positioning it as a leader in neurostimulation technology for spinal cord injury and Parkinson's disease. This creates opportunities to collaborate or supply advanced medical components with hospitals and clinics adopting their therapies.

Growing US Market The recent launch of the ARC-EX System in the US indicates expanding market penetration and a strong potential demand for neurostimulation devices tailored to spinal injury rehabilitation, highlighting sales opportunities with healthcare providers and rehabilitation centers.

Strong Funding Momentum With significant investments, including a EUR 50 million private placement and grants totaling over $2.5 million, ONWARD Medical demonstrates robust financial backing that supports ongoing product development and commercialization, enabling sales teams to target expanding product lines effectively.

Collaborations & Grants Partnerships with leading academic institutions and grants from prestigious foundations like the Christopher & Dana Reeve Foundation suggest heightened credibility and validation, opening doors for partnerships with research hospitals, academic centers, and device distributors.

Technical & Market Edge Utilizing advanced technologies and a strategic presence in Europe and the US, ONWARD Medical is well-positioned to serve neurostimulation markets globally. Business development efforts can focus on leveraging their innovative approach to secure distribution agreements and strategic alliances.